discoveries

Welcome to the 'discoveries' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'discoveries'.

Are you an expert about 'discoveries'? Do you want to be the Technorati authority on 'discoveries'? You can write a description that will appear right here: Join Blogcritics!

Latest blogosphere posts tagged “discoveries”

 

• Pacific Shore Holdings Retains Investor Relations Firm

  
  — Authority:
  CHATSWORTH, Calif., May 20, 2013 /PRNewswire/ -- (PSHR) Pacific Shore Holdings, Inc. a consumer products company providing naturally based products across a broad range of product categories lines, today reports that the company has retained investor relations firm, BlueWater...
  1 day ago

• Daybreak Continues Development Success at California Oil Project

  
  — Authority:
  SPOKANE, Wash., May 20, 2013 /PRNewswire/ -- Daybreak Oil and Gas, Inc. (OTCBB: DBRM) ("Daybreak" or the "Company"), a Washington corporation, is pleased to announce the results of the third well in the current drilling program at the East Slopes Project in Kern County, California....
  1 day ago

• New Study Identifies the Optimal Dose of Intravenous Vitamin C for Future Anticancer Clinical Trials

  
  — Authority:
  SCHAUMBURG, Ill., May 20, 2013 /PRNewswire-USNewswire/ -- The use of vitamin C to treat cancer patients first became popular in the 1970s as a result of the work of Nobel Laureate Linus Pauling.  However, studies conducted with orally dosed supplements did not demonstrate any...
  1 day ago

• The WIRB-Copernicus Group Partners with Mytrus, Inc. to Deliver Revolutionary, Interactive Electronic Informed Consent Solution

  
  — Authority:
  PRINCETON, N.J., May 20, 2013 /PRNewswire/ -- The WIRB-Copernicus Group, the worlds largest provider of regulatory and ethical review services for human research, announced today that it has partnered with Mytrus, Inc., a pioneer in "virtual clinical trials" and technologies that improve...
  1 day ago

• For Chronic Obstructive Pulmonary Disease, Surveyed Pulmonologists Indicate That Improved Effect on Quality of Life is One of the Greatest Unmet Needs

  
  — Authority:
  BURLINGTON, Mass., May 20, 2013 /PRNewswire/ -- Decision Resources, one of the worlds leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European pulmonologists agree that therapies offering a greater effect on quality of life is...
  1 day ago

• AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy

  
  — Authority:
  NORTH CHICAGO, Ill., May 20, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced today the initiation of a Phase 3 clinical study called SONAR (Study Of Diabetic Nephropathy with Atrasentan) to assess the effects of the investigational compound atrasentan - when added to standard...
  1 day ago

• Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania

  
  — Authority:
  ROCKVILLE, Md., May 20, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported that Eva Feldman, MD, PhD, principal investigator, presented updated Phase I data from its spinal cord-derived human neural stem cell (NSI-566) trial in the treatment of...
  1 day ago

• Smallest liquid droplets created at LHC are 100,000th the size of a hydrogen atom

  
  — Authority:
  Scientists closely working with the   Large Hadron Collider , the largest and most powerful particle accelerator in the world, have identified evidence of the minuscule droplets produced in the aftermath of high energy proton and lead ions collisions. If their calculations are right, then these are the smallest ...
  1 day ago

• Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes

  
  — Authority:
  BOSTON, May 20, 2013 /PRNewswire/ -- Rhythm announced today the results of a second Phase 1b clinical trial of RM-131, the companys novel ghrelin agonist for the treatment of diabetic gastroparesis in type 1 diabetic patients. The trial demonstrated that RM-131 significantly accelerates...
  1 day ago

• Sports Medicine New Frontiers: Platelet-Rich-Plasma (PRP) and Stem Cell Therapy

  
  — Authority:
  CLEARWATER, Fla., May 20, 2013 /PRNewswire/ -- Sports Medicine is always at the forefront of innovative medical technology.  Athletes are constantly striving to improve. Records are broken as humans run faster, jump higher, and strive for higher levels of performance. Athletes expose...
  1 day ago

• Intercept Pharmaceuticals Announces Positive Initial Results from Ongoing Phase 2a Trial in Chronic Bile Acid Diarrhea

  
  — Authority:
  NEW YORK, May 20, 2013 /PRNewswire/ --  Intercept Pharmaceuticals, Inc. ("Intercept", NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat chronic liver diseases, today announced positive...
  1 day ago

• Cempra Presents Post-Phase 2 Analysis of Solithromycins Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)

  
  — Authority:
  CHAPEL HILL, N.C., May 20, 2013 /PRNewswire/ -- Cempra, Inc. (Nasdaq: CEMP), a clinical-stage pharmaceutical company focused on developing differentiated antibiotics to meet critical medical needs in the treatment of bacterial infections, today announced that it presented data at the...
  1 day ago

• Final STRATO Clinical Study Data Demonstrates Potential for LCP-Tacro™ to Improve Tacrolimus-Induced Tremors

  
  — Authority:
  HORSHOLM, Denmark, May 20, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced that data from the STRATO study demonstrates the potential for LCP-Tacro™ to improve tacrolimus-induced tremors in stable kidney transplant patients.  The study,...
  2 days ago

• Awesome Image of the Total Solar Eclipse

  
  — Authority:
  This is so incredibly beautiful. Click image to embiggen. Shot by Czech photographer Miloslav Druckmüller from the Brno University of Technology, these amazing composite images capture the moon during a total solar eclipse revealing a vast solar corona. To achieve the crystal clear effect the shots are ...
  1 week ago

• Data From More Than 100,000 Boston Scientific Implantable Defibrillators Show Battery Longevity Projections Of Nine To 13 Years

  
  — Authority:
  NATICK, Mass., May 10, 2013 /PRNewswire/ -- New data from 100,438 patients with Boston Scientific Corporation (NYSE:BSX) implantable cardiac defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) followed in the LATITUDE™ Patient...
  1 week ago

• Third Party Presented New Data at the ARVO 2013 Annual Meeting in Seattle, WA, Validating the use of A3 Adenosine Receptor Agonists for Lowering Intra Ocular Pressure and for the Treatment of Glaucoma

  
  — Authority:
  PETACH TIKVA, Israel, May 10, 2013 /PRNewswire/ -- OphthaliX, Inc. (OTC BB: OPLI), announced today that it has come to its knowledge that Professor M. Francesca Cordeiro, a Professor of Glaucoma & Retinal Neurodegeneration Studies from UCL and Imperial College in London,...
  1 week ago

• Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update

  
  — Authority:
  ROCKVILLE, Md., May 10, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) today reported its financial results for the three months ended March 31, 2013 and provided a business and clinical update. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)"The Company...
  1 week ago

• Galectin Therapeutics Reports First Quarter 2013 Financial Results

  
  — Authority:
  NORCROSS, Ga., May 10, 2013 /PRNewswire/ -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today reported its financial results for the first quarter, ended March 31, 2013. These results are...
  1 week ago

• BREO™ ELLIPTA™ gains US approval for the treatment of COPD

  
  — Authority:
  LONDON and SOUTH SAN FRANCISCO, Calif., May 10, 2013 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the US Food and Drug Administration (FDA) has approved BREO™ ELLIPTA™ as an inhaled long-term, once-daily...
  1 week ago

• Celladon Corporation et SIRO Clinpharm annoncent une présentation lors de la « Statisticians in the Pharmaceutical Industry International Conference »

  
  — Authority:
  BOMBAY, Inde, May 10, 2013 /PRNewswire/ --- Analyse des hospitalisations récurrentes pour insuffisance cardiaque en présence de censure informative - Application du modèle de fragilité joint -Celladon Corporation, une société biopharmaceutique qui se...
  1 week ago

Comments about discoveries